Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Taylor Wimpey, Redrow, Diageo, Travis Perkins

(Sharecast News) - JPMorgan Cazenove downgraded Taylor Wimpey and Redrow on Wednesday as it took a look at housebuilders. "While it is tempting to turn optimistic on the UK Housebuilding sector following the recent moderation in interest rate expectations, we remain cautious with activity levels going through a seasonal lull over the next few months and relatively elevated valuations in the mid-cap space," JPM said. "We revise our estimates, which now stand 7% below consensus for 2023-25."

JPM downgraded Redrow to 'underweight' from 'neutral' and cut its price target on the stock to 390.0p from 550.0p as it sees the stock's valuation being vulnerable as soon as the buyback program completes.

Meanwhile, Taylor Wimpey was cut to 'neutral' from 'overweight' and its price target was reduced to 110.0p from 170.0p.

Analysts at Deutsche Bank lowered their target price on drinks maker Diageo from 3,350.0p to 3,160.0p on Wednesday as they adjusted their numbers on the stock ahead of its first-half results on 26 January.

Deutsche Bank expects to see Diageo deliver organic sales growth of 5.3%, organic operating profit growth of 4.0%, reported sales of £9.07bn, reported underlying earnings of £3.14bn, and earnings per share of 97.2p.

The German bank highlighted that having not given guidance at the time of its full-year results, it does not expect explicit 2023 guidance to be given along with the interim results.

However, DB expects the company to reiterate its medium-term guidance of 5-7% organic sales growth and operating profit growth of 6-9% for 2023-25.

Deutsche Bank, which reiterated its 'sell' rating on the stock, added that commentary around consumer demand, particularly downtrading, and cost pressures will likely be the "key" components of Diageo's interims.

Liberum downgraded Travis Perkins to 'hold' from 'buy' on Wednesday, as it took "a more selective stance".

In a broader note on building materials and equipment hire, the broker said it sees outperformance more likely in shares of companies with clearer growth records or differentiators.

"We expect the housing market to soften on raised mortgage rates and lower confidence, but Travis has a good track record of cutting overheads if demand falls and it can reduce inventories and rein in capex to protect further its strong balance sheet," it said. "The shares look cheap, especially on a sum of the parts basis, but renewed performance will need rate expectations and inflation to peak."

Liberum said it sees little upside to its unchanged and conservative target price of 960.0p but noted that while TP's Toolstation wing was unprofitable after European losses, it noted the offering was fast growing and comes with a very strong franchise.

"We use a sum of the parts analysis, putting a relatively low multiple (8x) on Merchanting and valuing Toolstation using a discounted cash flow (less a 30% discount)," it said.

Share this article

Related Sharecast Articles

Broker tips: SThree, M&S, Hollywood Bowl
(Sharecast News) - Jefferies cut its target price on SThree on Tuesday after the group's warning highlighted further downside to earnings for UK staffers.
Broker tips: Compass, Moonpig
(Sharecast News) - Analysts at Berenberg raised their target price on food service business Compass Group from 2,460.0p to 2,900.0p on Monday, stating the company was in possession of "all the ingredients for sustained growth".
Broker tips: Greggs, Impax Asset Management
(Sharecast News) - RBC Capital Markets recommended that investors "buy the dip" on Friday as it initiated coverage of bakery chain Greggs with an 'outperform' rating and 3,240.0p price target.
Broker tips: Diageo, SThree
(Sharecast News) - Diageo fizzed higher on Thursday as UBS upgraded the shares to 'buy' from 'sell and hiked the price target to 2,920p from 2,300p, saying it sees upside risks to the US business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.